Showing results (441-450 of 653) with videos related to

Sort By:
Pageof 66
BMJ Open|March 4, 2016
Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trialMorten Lindhardt, Frederik Persson, Gemma Currie, et al.
Diabetes, Obesity & Metabolism|October 10, 2023
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysisNikolaos Perakakis, Stefan R Bornstein, Andreas L Birkenfeld, et al.
Advances in Therapy|March 24, 2026
Evidence-Based Positioning of Sodium-Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Management of Chronic Kidney Disease with Type 2 Diabetes and Overweight or Obesity: A Systematic Literature ReviewYehuda Handelsman, Alice Y Y Cheng, Gian Paolo Fadini, et al.
European Heart Journal|April 22, 2025
Incident hyperkalaemia risk model in chronic kidney disease and diabetes: the FIDELITY programmeJoão Pedro Ferreira, Stefan D Anker, Biff F Palmer, et al.
BMJ Open Diabetes Research & Care|December 3, 2014
Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemiaNatalie A Bello, Marc A Pfeffer, Hicham Skali, et al.
Annals of Internal Medicine|December 4, 2023
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation AnalysisRajiv Agarwal, Wanzhu Tu, Alfredo E Farjat, et al.
JAMA Cardiology|June 14, 2023
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With FinerenoneRajiv Agarwal, Bertram Pitt, Peter Rossing, et al.
Annals of Internal Medicine|December 5, 2022
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKDMeir Schechter, Niels Jongs, Glenn M Chertow, et al.
Nephron|August 16, 2023
Hepatic Fibrosis Evaluated in Patients with Type 2 Diabetes with and without Chronic Kidney DiseaseTherese Adrian, Mads Hornum, Filip Krag Knop, et al.
Journal of Clinical Medicine|July 9, 2022
Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled TrialNinna H Tougaard, Marie Frimodt-Møller, Hanne Salmenkari, et al.
Pageof 66